BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world’s first and only multi-center ...
Please provide your email address to receive an email when new articles are posted on . HOLLYWOOD, Fla. — In patients with acute submassive pulmonary embolism, treatment with tissue plasminogen ...
Please provide your email address to receive an email when new articles are posted on . Catheter-directed thrombolysis was linked to less major bleeding than mechanical thrombectomy in patients with ...
BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation, a BTG International group company (BTG plc (LSE:BTG)), announced the publication of results of the SEATTLE II trial in the JACC: Cardiovascular ...
Patients admitted with an acute pulmonary embolism have improved in-hospital survival when treated with catheter-directed vs systemic thrombolysis, suggests a study published online August 26, 2015, ...
Table 1. Medical–surgical interventions to treat deep vein thrombosis. Approaches Indications for DVT Technical purpose Considerations Ref. Systemic anticoagulation Accepted conservative gold standard ...
A modified reperfusion protocol for intermediate-risk pulmonary embolism (PE) seemed to work without causing excessive bleeding in the small randomized CANARY trial. Use of conventional ...
SAN FRANCISCO, CA—A novel method of delivering drug therapy via ultrasound assistance appears effective in reversing right ventricular enlargement and dysfunction in patients with submassive pulmonary ...
Randomized Controlled Multi-Center Trial Demonstrates Reduced Treatment Time and Drug Dose with EKOS vs. Catheter-Directed Thrombolysis in Peripheral Arterial Occlusions EKOS Corporation, a privately ...
PMT devices can be used as an adjunct to CDT for the aggressive treatment of acute DVT. Although there are no randomized control trials comparing mechanical thrombectomy versus CDT, it is likely that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results